Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer

Seminars in Oncology

Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 47-50

  Von Pawel, J ^a   Wagner, H ^a   Niederle, N ^a   Heider, A ^a   Koschel, G ^a   Hecker, D ^a   Hanske, M ^a  

^a ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISPLATIN; CLEMASTINE; DEXAMETHASONE; PACLITAXEL; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ALOPECIA; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; NEUTROPENIA; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; REMISSION INDUCTION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0030463419     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)